Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients

Status

Completed

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00337038

Enrollment

Registered

2006-06-15

Start date

2006-06-30

Completion date

2010-07-31

Last updated

2012-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2, Hypertension

Brief summary

Our aim is to examine the influence of blood pressure and glycemic control together with N-acetylcystein utilization on the endothelia function of hypertensive diabetic patient.The study population will include 50 diabetic patient with uncontrolled hypertention that will be recruited from the Hypertension Clinic of Soroka University Medical Center.

Interventions

DRUGN-acetylcystein(drug)

p.O t.Siran 200mg x1 during one weak

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diabetic patients with uncontrolled hypertension that will be recruited from the Hypertension Clinic of Soroka University Medical Center

Exclusion criteria

* Pregnancy,secondary hypertention,malignancy or other serious illness

Design outcomes

Primary

Measure	Time frame
endothelial function	half of year

Secondary

Measure	Time frame
blood pressure and glycemic control	half of year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026